Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

New, physiologically balanced plasma volume expander now available in the U.S.

July 15, 1999

International patent covers Kowa's new ACAT inhibitors

July 15, 1999

Positive results announced for D-chiro-inositol in type II diabetes trial

July 15, 1999

Preclinical trials demonstrate neuroprotective activity of Vertex's neurophilin compounds

July 15, 1999

New integrin receptor antagonists in the Merck pipeline

July 14, 1999

Insulin secretion enhancers under study at Lilly for use in conditions of impaired glucose disposal

July 14, 1999

Vivus terminates agreement with Bio-Medic Institute

July 14, 1999

SomatoKine given orphan drug status as treatment of severe burns

July 13, 1999

U.S. patent covers Immucon's novel male contraceptive vaccine technology

July 13, 1999

Disappointing phase II trial results for Ergoset in the treatment of obesity

July 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...